NVWM LLC’s Definium Therapeutics DFTX Stock Holding History

NVWM LLC’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.6K	Hold	416	–	–	﹤0.01%	277
2026 Q1	$7.86K	Hold	416	–	–	﹤0.01%	319
2025 Q4	$5.57K	Hold	416	–	–	﹤0.01%	349
2025 Q3	$4.91K	Hold	416	–	–	﹤0.01%	349
2025 Q2	$2.7K	Hold	416	–	–	﹤0.01%	384
2025 Q1	$2.43K	Hold	416	–	–	﹤0.01%	369
2024 Q4	$2.9K	Hold	416	–	–	﹤0.01%	347
2024 Q3	$2.37K	Hold	416	–	–	﹤0.01%	361
2024 Q2	$3K	Hold	416	–	–	﹤0.01%	341
2024 Q1	$3.91K	Hold	416	–	–	﹤0.01%	325
2023 Q4	$1.52K	Buy	+416	New	+$1.25K	﹤0.01%	369

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

NVWM LLC's DFTX Position: Q2 2026 in Review

NVWM LLC held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 416 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

NVWM LLC first reported a position in DFTX in Q4 2023 and has held it in 11 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

NVWM LLC held 416 shares of Definium Therapeutics worth $19.6K as of Q2 2026.
NVWM LLC left its Definium Therapeutics share count unchanged in Q2 2026.
Definium Therapeutics made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #277 holding.
NVWM LLC first reported a position in Definium Therapeutics in Q4 2023 and has held it in 11 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.